Delivery Order SPE2DB20D3103-SPE2DB24FN5M7
Award Date 4/23/24
Potential Completion Date 5/14/24
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $13,862.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Zeposia 0.92 MG Capsule 30S, with a completion date of May 1, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,441.87 firm fixed price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $4,620.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of the medication Zeposia 0.92 mg capsule 30s, a prescription drug used for the treatment of certain medical conditions. The contract is a delivery order with a firm fixed price and an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPK16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Zeposia 0.92 MG Capsule 30S, with a ceiling value of $4,620.93 and a completion date of February 26, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,862.79 fixed-price contract is for the supply of the prescription medication Zeposia 0.92 mg capsules. The contract has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication Zeposia 0.92 mg Capsule 30s, with a ceiling value of $13,862.79 and a performance period through May 21, 2025. This contract is not set-aside and was awarded as part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,466.57, is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,620.93 delivery order is for the supply of Zeposia 0.92 mg capsules, a specialty medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This federal contract award, valued at $4,466.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zeposia 0.92 MG capsules, a prescription medication, with a completion date of November 8, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a Set-Aside contract. The contract is a child order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,399.71 firm fixed price delivery order is for the supply of 4,565,730,589 units of Zeposia 0.92 MG Capsule 30S, a specialty pharmaceutical product. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...